4022 related articles for article (PubMed ID: 7044959)
1. Delayed-type hypersensitivity and allograft rejection in the mouse: correlation of effector cell phenotype.
Loveland BE; McKenzie IF
Immunology; 1982 Jun; 46(2):313-20. PubMed ID: 7044959
[TBL] [Abstract][Full Text] [Related]
2. The role of T4+ and Ly-2+ cells in skin graft rejection in the mouse.
Wheelahan J; McKenzie IF
Transplantation; 1987 Aug; 44(2):273-80. PubMed ID: 3114924
[TBL] [Abstract][Full Text] [Related]
3. T cell subsets in the immune rejection of murine heterotopic corneal allografts.
Matoba AY; Peeler JS; Niederkorn JY
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1244-54. PubMed ID: 2942516
[TBL] [Abstract][Full Text] [Related]
4. Cells mediating graft rejection in the mouse. II. The Ly phenotypes of cells producing tumor allograft rejection.
Loveland BE; McKenzie IF
Transplantation; 1982 Feb; 33(2):174-80. PubMed ID: 7036470
[TBL] [Abstract][Full Text] [Related]
5. Cells mediating graft rejection in the mouse. IV. The Ly-5, 6, and 8 effector cell phenotype.
Loveland BE; McKenzie IF
Transplantation; 1982 Apr; 33(4):411-3. PubMed ID: 6978559
[TBL] [Abstract][Full Text] [Related]
6. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
Joo CK; Pepose JS; Stuart PM
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
[TBL] [Abstract][Full Text] [Related]
7. The role of epidermal cells in the induction of delayed-type hypersensitivity to alloantigens.
Tamaki K; Furue M
J Invest Dermatol; 1985 Jul; 85(1):20-4. PubMed ID: 3891874
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
[TBL] [Abstract][Full Text] [Related]
9. Cells mediating graft rejection in the mouse. III. Ly-1+ precursor T cells generate skin graft rejection.
Loveland BE; McKenzie IF
Transplantation; 1982 Apr; 33(4):407-10. PubMed ID: 7041367
[TBL] [Abstract][Full Text] [Related]
10. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection.
Sirak J; Orosz CG; Wakely E; VanBuskirk AM
Transplantation; 1997 May; 63(9):1300-7. PubMed ID: 9158025
[TBL] [Abstract][Full Text] [Related]
11. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
12. Prolonged Hya-disparate skin graft survival in ethanol-consuming mice: correlation with impaired delayed hypersensitivity.
Wang K; Busker-Mannie AE; Hoeft J; Vasquez K; Miller SD; Melvold RW; Waltenbaugh C
Alcohol Clin Exp Res; 2001 Oct; 25(10):1542-8. PubMed ID: 11696676
[TBL] [Abstract][Full Text] [Related]
13. DNA associated with the cell membrane is involved in the inhibition of the skin rejection response induced by infusions of photodamaged alloreactive cells that mediate rejection of skin allograft.
Perez MI; Yamane Y; John L; Gasparro FP; Edelson RL
Photochem Photobiol; 1992 Jun; 55(6):839-49. PubMed ID: 1409891
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of anti-skin allograft immunity induced by infusions with photoinactivated effector T lymphocytes--the congenic model.
Perez MI; Berger CL; Yamane Y; John L; Laroche L; Edelson RL
Transplantation; 1991 Jun; 51(6):1283-9. PubMed ID: 1828639
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes.
Perez M; Edelson R; Laroche L; Berger C
J Invest Dermatol; 1989 May; 92(5):669-76. PubMed ID: 2523941
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells).
Perez MI; Edelson RL; John L; Laroche L; Berger CL
Yale J Biol Med; 1989; 62(6):595-609. PubMed ID: 2636801
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between early acting delayed-type hypersensitivity T-cells and cultured effector cells in tumor rejection.
Trial J
Cancer Res; 1988 Nov; 48(21):5922-6. PubMed ID: 3262417
[TBL] [Abstract][Full Text] [Related]
18. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
Ptak W; Herzog WR; Askenase PW
J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
[TBL] [Abstract][Full Text] [Related]
19. Delayed-type hypersensitivity to transplantation antigens in mice and its investigation under conditions of allograft and xenograft tolerance.
Chernyakhovskaya IYu ; Lyadova IV
Folia Biol (Praha); 1987; 33(3):166-76. PubMed ID: 3497824
[TBL] [Abstract][Full Text] [Related]
20. Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.
Loveland BE; Hogarth PM; Ceredig R; McKenzie IF
J Exp Med; 1981 May; 153(5):1044-57. PubMed ID: 7019377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
